Arrowhead报告胰腺炎发病率降低及早期胆固醇药物结果（ARWR:NASDAQ）
· seekingalpha.com
Arrowhead的plozasiran在后期研究中将胰腺炎发病率降低了78%。
Worsening blood-sugar control occurred in 14% of plozasiran recipients versus 8.7% on placebo. Overall health problems occurred at similar rates in both groups,...